HCA Healthcare, Inc.HCA
Recorded

HCA Healthcare, Inc. Healthcare Services and Technology Conference

Review the key takeaways and the transcript of this earnings call.

Period 0Duration32 minParticipants2

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Brian TanquilutAnalyst

All right. Good afternoon. I know we're running a little late here. Our next presenter is HCA. With us today is the company CFO, Mike Marks. Mike, thank you for doing this. Well, let's see. Since we're in Nashville Yep healthcare services capital, maybe let's start with how you view the state of the hospital industry, especially as we consider things like the expiration of HICS, One Big Beautiful Bill, macro, demographic trends.

Brian TanquilutAnalyst

People are always asking, what does the hospital industry look like today?

Mike MarksCFO

Yeah, it's a dynamic environment for the industry on the hospital side for sure, and you've noted some of the biggest moving parts. On the headwind side, we're kind of halfway through the end of second quarter, the first year of the reform to the exchanges with the expiration of the EHITCs. So that's the biggest moving part for not just for HCA, but really for the industry as we sit here halfway through 2026. There's some positive aspects, too. I think for the industry, certainly for HCA, the demand environment continues to be good. We are seeing overall strong demand, at least in our markets, for healthcare services.

Mike MarksCFO

While the exchanges have had a payer mix dynamic under that where people are losing coverage on the exchanges and becoming uninsured, so we're dealing with that pressure, the fundamentals of demand are still strong. Second quarter, and again, I'll use HCA as a proxy, but for second quarter, our insured business, excluding the exchanges, were up 3.2% over prior year. That is a good number when I think about our commercial business, our Medicare and Medicaid business. So demand's good. The policy framework is always such that there's some negative aspects and some positive aspects. In the One Big Beautiful Bill, I think the headlines are the SDP reform and work requirements. But part of this was grandfathering, and HCA was fortunate. We had five states, including one of our largest states, that had this opportunity under the One Big Beautiful Bill to enhance our programs.

Mike MarksCFO

Our states, those five states were able to execute on that. Over the last 6 months here, we've seen all five states now move through to approval. The policy gods taketh away, and the policy gods giveth. In this one, it's a real benefit, and it's helping us navigate some of the negative headwind challenges. There are other aspects, I think, longer term, the industry, we're starting to look at the reform of Medicaid under the One Big Beautiful Bill and how to navigate that. Then I think the whole industry is working through resiliency. We certainly are, and we'll talk about that as we go through today. That's the pace of play. It's a reform environment. It's a dynamic environment. I think the stronger players are navigating through these challenges. Then you got to get to specifics.

Brian TanquilutAnalyst

Let's get to specifics then.

Brian TanquilutAnalyst

Let's do it. No, more HCA specifics.

Brian TanquilutAnalyst

When we think about the second quarter, a lot of moving pieces to unpack. A guidance change, softer surgical volumes, but on the flip side, you bought back a lot of stock. When we think of the guidance for the back half of the year that you've laid out, how do we put the pieces together to bridge us from what was first half into the back half of the year?

Mike MarksCFO

Yeah, if you think about the moving parts in our second half guidance that was implied, there are really three or four key moving parts. You have noted one, which is the update to our exchange impact. Based on what we have learned here through the first six months, we did update the negative impact to $1 billion-$1.2 billion, based on what we have learned through the first half. That is a big moving part. The second piece here would be the state supplemental payments. With all the grandfathering applications that are now approved and with the pickup that we were able to record in second quarter related to Florida, we now believe that that is a $300 million-$500 million net benefit for the year, which is a positive thing. I think second quarter also highlighted the improvement in the volume story.

Mike MarksCFO

In the first quarter, our volumes were disrupted a little bit with the winter storm and with the kind of sudden stop to the respiratory season. Second quarter pulled right back. We saw 2.5% admission growth, 2.7% on AA growth and, as I have already noted, good results on our insured book, excluding exchanges. We were pleased in our overall guidance, and that includes our belief that that volume growth will continue here through the back half of the year, and that is important. The other component really that is embedded in our guidance update is cost. For second quarter, our resiliency plan produced a good output on our cost management efforts. We believe, given the line of sight we have with resiliency and the actions that we are taking, that it will even be a bit stronger here in the back half of the year.

Mike MarksCFO

As I think about the rest of the year, I am really pleased with where we are and where we are going. We also took the time to just realize where we were and adjust the guidance accordingly with those factors. We will update you when third quarter comes.

Brian TanquilutAnalyst

So maybe if I may double-click on that, one of the questions we are getting asked a lot is the visibility into EHITCs, right? You adjusted your guidance. A lot of investors are asking, how comfortable or confident are you in that revised guidance range, and what gives you the visibility to say it is going to be $1.2 billion or $1.1 billion midpoint?

Mike MarksCFO

Well, what we did is what we always do. Given the dynamic nature of the exchanges, it is the biggest moving part that we have this year, as I have noted. We took what we have learned through the first six months, we made our best estimates for the back half of the year, and then we set a range. We have this range of $1 billion to $1.2 billion. The only other thing I would note here is that there is a bit of a fourth quarter comparison factor here. In hindsight, when you look back at fourth quarter of 2025, we were already starting to see some of the effects of reform. One example of that would be the suspension of the special enrollment period for low-income people. Fourth quarter of 2025 was up only about 2.5% over prior year.

Mike MarksCFO

The full year was over 10% growth in 2025 versus 2024. Even sequentially, typically, fourth quarter would be the peak of our exchange volumes out of the four quarters of the year. In fourth quarter of 2025, we actually saw a 5,000 decline from third quarter to fourth quarter on equivalent admissions. The slowdown started in fourth quarter of last year, and so that is a piece of the story in terms of our second half of 2026 versus second half of 2025. It is one of the reasons why we highlighted that we thought fourth quarter's growth rate would be a little better than third quarter's, is this dynamic on year-over-year comparison on exchanges. It is a dynamic moving part for us.

Mike MarksCFO

What we always try to do is give our best judgments and estimate based on what we have seen, and that is what we did at second quarter.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

More recent earnings calls

View earnings calendar